Search

everythinglearnresearchcommunity

for

Search:↓

The Wnt/β-catenin pathway helps tissue regeneration but can also cause fibrosis, and drugs that inhibit this pathway may aid in healing skin and heart tissues.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Nitric oxide is important for skin functions and both helps protect against and contributes to skin inflammation and sensitization.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Aging mice have slower hair regeneration due to changes in signal balance, but the environment, not stem cell loss, controls this, suggesting treatments could focus on environmental factors.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Targeting colon cancer stem cells might lead to better treatment results.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Ruxolitinib treatment may cause eyelash growth.

iNOS contributes to hair loss in obese diabetic mice and blocking it may encourage hair growth.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

Inhibiting ODC can prevent UV-induced skin cancer.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.